Viewing Study NCT05626751


Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2025-12-30 @ 11:31 PM
Study NCT ID: NCT05626751
Status: TERMINATED
Last Update Posted: 2025-03-12
First Post: 2022-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc)
Sponsor: Amgen
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-11-04
Start Date Type: ACTUAL
Primary Completion Date: 2025-02-24
Primary Completion Date Type: ACTUAL
Completion Date: 2025-02-24
Completion Date Type: ACTUAL
First Submit Date: 2022-11-01
First Submit QC Date: None
Study First Post Date: 2022-11-25
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-03-10
Last Update Post Date: 2025-03-12
Last Update Post Date Type: ACTUAL